S. Paul, N. Jayaraman / Carbohydrate Research 339 (2004) 2197–2204
2203
1
3
was continued for 15h at room temperature, the reac-
2.07 (s, 3H, COCH ), 1.33 (t, 3H, J = 7.5Hz, CH );
3
C
3
tion mixture extracted with ether, dried, concentrated
in vacuo. The resulting crude product was subjected to
column chromatography to afford 2-deoxy-1-thioglyco-
sides.
NMR (CDCl , 75MHz) d : 170.57, 170.29, 131.99 (C-2),
3
123.67 (C-3), 79.68 (C-1), 66.61(C-4), 63.43 (C-5), 62.65
(C-6), 25.59(SCH ), 20.79, 20.71, 15.21. b-anomer (13):
2
1
H NMR (CDCl , 300MHz) d : 5.87–5.77 (m, 2H, H-3,
3
H-2), 5.29(app. s, 1H, H-1), 5.07–5.04 (m, 1H, H-4),
4.20–4.24 (m, 2H, H-6a, H-6b), 3.98–3.90 (m, 1H, H-
3.3. Ethyl 2-deoxy-3,4,6-tri-O-acetyl-1-thio-a-D-lyxo-
hexopyranoside (5)
5), 2.53–2.65 (m, 2H, SCH ), 2.09(s, 3H, COCH 3),
2
2.07 (s, 3H, COCH ), 1.32 (t, 3H, J = 7.5Hz, CH ).
3 3
3
CHCl3). HR-MS: m/z calcd for C H O SNa =
9%; R = 0.45 (35% EtOAc/pet.ether); [a] +263 (c 1.2,
HR-MS: m/z calcd for C H O SNa = 297.0773.
12 18 5
f
D
Found: 297.0763.
14
22
7
3
57.0984. Found: 357.0970.
3.10. Ethyl 4,6-di-O-acetyl-2,3-dideoxy-1-thio-D-erythro-
hex-2-enopyranoside
1
8
3.4. Ethyl 2-deoxy-3,4,6-tri-O-acetyl-1-thio-b-D-lyxo-
hexopyranoside (6)
5
5%; R = 0.32 (15% EtOAc/pet.ether). a-anomer (14):
f
1
3
CHCl3). HR-MS: m/z calcd for C H O SNa =
1%; R = 0.38 (35% EtOAc/pet.ether); [a] +29( c 1.00,
H NMR (CDCl , 300MHz) d: 5.94 (dd, 1 H, J = 2.1,
f
D
3
10.5Hz, H-3), 5.78 (d, 1H, J = 10.5Hz, H-2), 5.58 (br.
s, 1H, H-1), 5.37 (dd, 1H, J = 1.5, 9.3Hz, H-4), 4.35–
14
22
7
3
57.0984. Found: 357.0981.
4.15 (m, 3H, H-5, H-6a, H-6b), 2.79–2.59 (m, 2H,
SCH ), 2.09(br. s, 6H, COCH 3), 1.26 (t, 3H,
3.5. Ethyl 2-deoxy-3,4,6-tri-O-acetyl-1-thio-b-D-arabino-
hexopyranoside (7)
2
1
3
J = 7.5Hz, CH3);
C NMR (CDCl , 75MHz) d:
3
170.69, 170. 21, 129.04 (C-2), 126.71 (C-3), 80.02 (C-
1), 66.67 (C-4), 65.03 (C-5), 62.91 (C-6), 25.99 (SCH ),
3
CHCl ). HR-MS: m/z calcd for C H O SNa =
5%; R = 0.41 (35% EtOAc/pet.ether); [a]D À45 (c 1.2,
f
2
1
20.92, 20.69, 15.22. b-anomer (15): H NMR (CDCl ,
3
14 22
7
3
3
57.0984. Found: 357.1000.
300MHz) d: 5.94–5.85 (m, 2H, H-3, H-2), 5.40 (app. s,
1H, H-1), 5.29(app. d, 1H, J = 8.1Hz, H-4), 4.25–4.22
3.6. Ethyl 2-deoxy-3,4,6-tri-O-benzyl-1-thio-a-D-lyxo-
hexopyranoside (8)
(m, 2H, H-6a, H-6b), 3.88–3.82 (m, 1H, H-5), 2.75–
2.57 (m, 2H, SCH ), 2.09(br. s, 6H, COCH ), 1.29(t,
2
3
1
3
3
H, J = 7.5Hz, CH3); C NMR (CDCl , 75MHz) d:
3
5
0
5
1%; R = 0.44 (15% EtOAc/pet.ether); [a]D +133 (c
170.74, 170.15, 130.44 (C-2), 127.01 (C-3), 78.80 (C-1),
74.75 (C-4), 64.70 (C-5), 63.26 (C-6), 23.24 (SCH2),
20.92, 20.76, 15.04. HR-MS: m/z calcd for C H O S-
f
.98, CHCl ). HR-MS: m/z calcd for C H O SNa =
01.2076. Found: 501.2095.
3
29 34
4
1
2
18
5
Na = 297.0773. Found: 297.0777.
3.7. Ethyl 2-deoxy-3,4,6-tri-O-benzyl-1-thio-b-D-lyxo-
hexopyranoside (9)
3.11. Ethyl 4,6-di-O-benzyl-2,3-dideoxy-1-thio-D-erythro-
hex-2-enopyranoside
3
CHCl ). HR-MS: m/z calcd for C H O SK =
4%; R = 0.37 (15% EtOAc/pet.ether); [a] À29( c 0.94,
f
D
15%; R = 0.47 (15% EtOAc/pet.ether). a-anomer (16):
3
29 34
4
f
1
5
17.1815. Found: 517.1841.
H NMR (CDCl , 400MHz) d: 7.33–7.23 (m, 10H, aro-
3
matic-H), 5.95 (d, 1H, J = 10.2Hz, H-2), 5.85 (dd, 1H,
J = 1.8, 10.1Hz, H-3), 5.57 (br s, 1H, H-1), 4.66–4.45
3.8. Ethyl 2-deoxy-3,4,6-tri-O-benzyl-1-thio-D-arabino-
hexopyranoside (10, 11)
(m, 4H, PhCH ), 4.25 (dd, 1H, J = 1.7, 9.2Hz, H-4),
2
3.79–3.74 (m, 2H, H-5, H-6a), 3.69 (dd, 1H, J = 1.8,
10.6Hz, H-6b), 2.77–2.62 (m, 2H, SCH ), 1.28 (t, 3H,
68%; R = 0.33 (15% EtOAc/pet.ether). HR-MS: m/z
calcd for C H O SK = 517.1815. Found: 517.1837.
f
2
1
3
J = 7.4Hz, CH3); C NMR (CDCl , 100MHz) d:
3
2
9
34
4
138.18, 138.10, 128.39(C-2), 128.34, 127.8 ,9 127.88,
127.85, 127.77 (C-3), 80.29(C-1), 73.32 (C-4), 71.0,9
3.9. Ethyl 4,6-di-O-acetyl-2,3-dideoxy-1-thio-D-threo-
hex-2-enopyranoside
70.23, 68.99 (C-5), 68.87(C-6), 25.98 (SCH ), 15.32. b-
2
1
anomer (17): H NMR (CDCl , 400MHz) d: 7.31–7.24
3
9
%; R = 0.31 (15% EtOAc/pet.ether). a-anomer (12):
(m, 10H, aromatic-H), 6.01 (dd, 1H, J = 1.9, 10.2, H-
3), 5.81 (dd, 1H, J = 1.8, 10.2Hz, H-2), 5.37 (d, 1H,
f
1
H NMR (CDCl , 300MHz) d : 6.11 (dd, 1 H, J = 2.8,
3
1
0.2Hz, H-3), 6.02 (d, 1H, J = 10Hz, H-2), 5.66 (app.
s, 1H, H-1), 5.08 (dd, 1H, J = 2.4, 4.8Hz, H-4), 4.55
J = 1.8Hz, H-1), 4.58–4.41 (m, 4H, PhCH ), 4.18–4.15
2
(m, 3H, H-4, H-6a, H-6b), 4.07–4.09(m, 1H, H-5),
2.73–2.58 (m, 2H, SCH ), 1.26 (t, 3H, J = 7.4Hz,
(app. t, 1H, J = 4.9Hz, H-5), 4.27–4.22 (m, 2H, H-6a,
H-6b), 2.79–2.60 (m, 2H, SCH ), 2.09(s, 3H, COCH ),
2
1
3
CH3); C NMR (CDCl , 100MHz) d: 138.39, 137.91,
2
3
3